CEA Industries Inc. (as identified in request) — Filing summary
Important issuer discrepancy: The supplied filing is Surna Inc.’s Form 10-K, not a filing for CEA Industries Inc. Verify the issuer and filing before relying on this summary.
Business context and reporting period
The filing covers Surna Inc.’s fiscal year ended December 31, 2017, and was signed April 2, 2018. Surna designs, engineers, manufactures and distributes climate-control and air-sanitation systems for indoor cannabis cultivation facilities; it does not produce or sell cannabis. Shares traded on OTCQB under SRNA.
Financial results and liquidity
| Metric | FY 2017 | FY 2016 |
|---|---|---|
| Revenue | $7.210 million | $7.580 million |
| Gross profit / margin | $1.910 million / approximately 26% | $2.304 million / 30% |
| Operating expenses | $6.152 million | $2.837 million |
| Operating loss | $4.242 million | $0.533 million |
| Net loss | $4.919 million | $3.273 million |
| Basic and diluted loss per share | $0.03 | $0.02 |
| Cash used in operating activities | $2.267 million | Cash provided: $0.103 million |
At year-end, cash was $2.468 million, working capital was positive $0.308 million (versus a $2.860 million deficit a year earlier), and total liabilities were $3.416 million. Surna reported no indebtedness other than $6,927 due under a related-party note, which was subsequently paid; it also reported $410,880 in derivative liabilities. Accounts payable and accrued liabilities were $1.969 million and deferred revenue was $1.012 million.
Financing activities provided $4.621 million in 2017, including $4.453 million from common-stock-and-warrant offerings and $0.500 million from notes that were converted to equity. Accumulated deficit was $19.255 million. The auditor and management both cited substantial doubt about Surna’s ability to continue as a going concern.
Material changes and operating developments
- Revenue declined 5%, while gross margin fell about four percentage points. Management attributed the margin decline mainly to lower-margin engineering work and increased shipping costs.
- Operating expenses rose 117%, primarily reflecting higher stock-based compensation, salaries and benefits, legal and consulting costs, director compensation, and marketing. FY 2017 included $2.140 million of non-cash stock compensation.
- Net loss increased by $1.646 million. Lower debt discount amortization and interest expense reduced other expenses, but did not offset higher operating losses.
- Annual net bookings were $9.020 million; year-end backlog was $4.456 million. Fourth-quarter bookings were $2.454 million and recognized revenue was $2.309 million. About 41% of year-end backlog related to projects for which only an initial deposit had been received; backlog is not a guarantee of future revenue or profitability.
- Shares outstanding increased from 160.7 million at 2016 year-end to 206.2 million at 2017 year-end, primarily reflecting equity financings, debt conversions and compensation awards.
Outlook, risks and unusual items
- Funding: Management said cash and operating cash flow would be insufficient for the next 12 months and expected to need debt or equity financing in the second or third quarter of 2018. Financing may not be available on acceptable terms; failure to obtain it could require operational reductions.
- Business outlook: Surna planned to pursue projects in California, Canada and other regulated markets, grow backlog, and expand production space. It gave no firm revenue or earnings guidance. Sales cycles can last six months to two years, and revenue depends on customer licensing, financing, construction and equipment shipment.
- Industry and regulatory exposure: U.S. federal cannabis prohibition and the January 2018 rescission of the Cole Memo could affect customers, financing and Surna’s ability to operate in the sector. Canadian recreational legalization was anticipated but not certain at the time of filing.
- Controls: Management concluded disclosure controls and internal control over financial reporting were ineffective, citing insufficient accounting expertise and review, inadequate segregation of duties, and spreadsheet-control deficiencies. The material weakness remained unremediated.
- Contingencies and related parties: Surna disclosed approximately $115,000 of IRS penalties and interest related to late Forms 5471; it had appealed and recorded no accrual based on its view that abatement was likely. A commercial dispute settlement was accrued, including $332,418 in liabilities. Sterling Pharms, controlled by a principal shareholder, had equipment, testing and demonstration arrangements with Surna.
- Other items: A $1.177 million reduction in deferred tax assets from 2017 tax reform was fully offset by a valuation allowance. The filing reported no material legal proceedings and no off-balance-sheet arrangements.
Important facts for investors to verify
- Confirm the filing belongs to the intended company: the document names Surna Inc., not CEA Industries Inc.
- Review the full financial statements and notes for cash runway, the timing and terms of any subsequent financing, and the going-concern assessment.
- Assess the quality and collectability of the $4.456 million backlog, especially the portion supported only by initial deposits, and customer receivable concentration.
- Track remediation of the material weakness and any resulting changes to financial reporting reliability.
- Verify the status and resolution of the IRS appeal, commercial settlement, and related-party Sterling arrangements.
- Consider dilution from outstanding warrants, equity awards and subsequent share issuances, alongside the company’s ability to convert bookings into profitable revenue.